Yuyu Pharma, Inc.
Символ: 000220.KS
KSC
5100
KRWПазарна цена днес
-11.1067
Съотношение P/E
0.0857
Коефициент PEG
82.53B
MRK Cap
- 0.02%
Доходност на DIV
Yuyu Pharma, Inc. (000220-KS) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 103060.54 | 30604.9 | 30777.6 | 50263.5 | |||||||||||||||||
balance-sheet.row.short-term-investments | 6609.94 | 1749.3 | 4939.1 | -2909.2 | |||||||||||||||||
balance-sheet.row.net-receivables | 105320.57 | 24454.5 | 25308.8 | 22905.2 | |||||||||||||||||
balance-sheet.row.inventory | 181499.19 | 44152.2 | 39832 | 25225.3 | |||||||||||||||||
balance-sheet.row.other-current-assets | 3582.18 | 2384.9 | 439.3 | 494 | |||||||||||||||||
balance-sheet.row.total-current-assets | 393462.47 | 101596.5 | 96357.7 | 98887.9 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 326050.89 | 81402.7 | 81371.3 | 80341.4 | |||||||||||||||||
balance-sheet.row.goodwill | 864.67 | 503.2 | 50.8 | 50.8 | |||||||||||||||||
balance-sheet.row.intangible-assets | 15505.95 | 3764.5 | 3666.5 | 4087.1 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 16370.62 | 4267.7 | 3717.3 | 4137.9 | |||||||||||||||||
balance-sheet.row.long-term-investments | 28528.97 | 10815.2 | 1004.7 | 8945 | |||||||||||||||||
balance-sheet.row.tax-assets | 16931.16 | 3764.5 | -1004.7 | -8945 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 10614.46 | -3633.1 | 13758.7 | 9618.1 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 398496.09 | 96617 | 98847.3 | 94097.4 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 791958.56 | 198213.5 | 195205.1 | 192985.3 | |||||||||||||||||
balance-sheet.row.account-payables | 50041.57 | 10951.8 | 15840.5 | 8982.3 | |||||||||||||||||
balance-sheet.row.short-term-debt | 111167.67 | 25386.2 | 37425 | 10427.3 | |||||||||||||||||
balance-sheet.row.tax-payables | 3627.81 | 574.8 | 515.4 | 1004.5 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 57951.05 | 13640 | 1851.4 | 28739.1 | |||||||||||||||||
Deferred Revenue Non Current | 5198.12 | 380.9 | 0 | 2649.5 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 17759.78 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 24238.25 | 12247.1 | 10366.1 | 0 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 92996.28 | 27882.7 | 7515.5 | 34285.5 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 2486.97 | 380.9 | 793.8 | 697.8 | |||||||||||||||||
balance-sheet.row.total-liab | 306986.73 | 77857.9 | 71831 | 64300.2 | |||||||||||||||||
balance-sheet.row.preferred-stock | 10369.96 | 2592.5 | 2592.5 | 2592.5 | |||||||||||||||||
balance-sheet.row.common-stock | 70436.76 | 17609.2 | 17609.2 | 17609.2 | |||||||||||||||||
balance-sheet.row.retained-earnings | 92358.42 | 13946.5 | 31395.9 | 36540.4 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 41548.45 | 25885.4 | 23796 | 24242.5 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 240307.31 | 52154.1 | 41422.7 | 43296.7 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 455020.89 | 112187.6 | 116816.2 | 124281.2 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 784299.41 | 198213.5 | 195205.1 | 192985.3 | |||||||||||||||||
balance-sheet.row.minority-interest | 29950.93 | 8168 | 6557.8 | 4403.9 | |||||||||||||||||
balance-sheet.row.total-equity | 484971.83 | 120355.7 | 123374 | 128685.1 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 784299.41 | - | - | - | |||||||||||||||||
Total Investments | 33389.61 | 10815.2 | 5943.8 | 6035.9 | |||||||||||||||||
balance-sheet.row.total-debt | 169499.64 | 39407.2 | 39276.4 | 39166.5 | |||||||||||||||||
balance-sheet.row.net-debt | 71299.75 | 8802.3 | 13437.8 | -11097 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -6079.58 | -7180.9 | -4425.4 | -920.3 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 5607.33 | 5607.3 | 5027.4 | 4503 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 2698.8 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | -42.4 | |||||||||||||||||
cash-flows.row.change-in-working-capital | -6772.53 | -6772.5 | -13150.7 | -3703.6 | |||||||||||||||||
cash-flows.row.account-receivables | 918.94 | 918.9 | -1760.7 | -3016.3 | |||||||||||||||||
cash-flows.row.inventory | -3424.07 | -3424.1 | -15133.5 | -1366.8 | |||||||||||||||||
cash-flows.row.account-payables | -5527.35 | -5527.3 | 7090.7 | 3715.8 | |||||||||||||||||
cash-flows.row.other-working-capital | 1259.95 | 1260 | -3347.2 | -3036.3 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 7724.58 | 9185.2 | 6319.7 | 1973.2 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 479.81 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -5106.22 | -5106.2 | -5567.7 | -6750.9 | |||||||||||||||||
cash-flows.row.acquisitions-net | -1180.28 | -770.9 | 4.6 | 1029 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -606.01 | -606 | -3833.6 | -822.3 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 3035.44 | 3047.3 | 506 | 701.6 | |||||||||||||||||
cash-flows.row.other-investing-activites | 831.04 | -346.4 | 346.9 | -47 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -3026.03 | -3782.2 | -8543.8 | -5889.6 | |||||||||||||||||
cash-flows.row.debt-repayment | -28407 | -10449.7 | -6253.3 | -906.8 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -1785.2 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | -2001.73 | -2001.7 | -2033.7 | -1851.2 | |||||||||||||||||
cash-flows.row.other-financing-activites | 37721.24 | 20160.8 | 989.1 | 34071 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 7312.51 | 7709.4 | -9083.2 | 31313 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.01 | 0 | -568.9 | 8.6 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 4766.3 | 4766.3 | -24424.9 | 29940.6 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 98199.89 | 30604.9 | 25838.6 | 50263.5 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 93433.59 | 25838.6 | 50263.5 | 20322.8 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 479.81 | 839.1 | -6229 | 4508.7 | |||||||||||||||||
cash-flows.row.capital-expenditure | -5106.22 | -5106.2 | -5567.7 | -6750.9 | |||||||||||||||||
cash-flows.row.free-cash-flow | -4626.41 | -4267.1 | -11796.7 | -2242.2 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 137209.59 | 137209.6 | 138881.1 | 115655.5 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 88978.45 | 90704.5 | 85567.9 | 70320.1 | |||||||||||||||||
income-statement-row.row.gross-profit | 48231.14 | 46505.1 | 53313.1 | 45335.4 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 7187.64 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 26369 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 11707.31 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -28303.31 | -219.2 | 25291.4 | 23750.8 | |||||||||||||||||
income-statement-row.row.operating-expenses | 22970.6 | 47254.1 | 53905.3 | 44135.2 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 112820.26 | 137958.5 | 139473.2 | 114455.3 | |||||||||||||||||
income-statement-row.row.interest-income | 896.74 | 896.7 | 561.7 | 201 | |||||||||||||||||
income-statement-row.row.interest-expense | 3677.09 | 2553.8 | 2580.7 | 2175.4 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 11707.31 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -5386.11 | -4199.5 | -4502.1 | -3036.7 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -28303.31 | -219.2 | 25291.4 | 23750.8 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -5386.11 | -4199.5 | -4502.1 | -3036.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 3677.09 | 2553.8 | 2580.7 | 2175.4 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 27466.73 | 5607.3 | 5027.4 | 4503 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 26890.08 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | -169.19 | -748.9 | 691.7 | 2653.5 | |||||||||||||||||
income-statement-row.row.income-before-tax | -5555.29 | -4948.5 | -3810.4 | -383.2 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 98.44 | 98.4 | 615 | 537.1 | |||||||||||||||||
income-statement-row.row.net-income | -6818.85 | -7180.9 | -4425.4 | -920.3 |
Често задавани въпроси
Какво е Yuyu Pharma, Inc. (000220.KS) общи активи?
Yuyu Pharma, Inc. (000220.KS) общите активи са 198213526767.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 68699340722.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е -285.886.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е -285.886.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -0.050.
Какъв е общият приход на предприятието?
Общият приход е -0.001.
Каква е Yuyu Pharma, Inc. (000220.KS) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е -7180899668.000.
Какъв е общият дълг на фирмата?
Общият дълг е 39407153086.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 47254050269.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 30604882236.000.